21 May 2009
Myocardial fibrosis and cardiocyte diameter are the most important factors discriminating histostructure of dilatative and ischemic cardiomyopathy – study of hearts explanted from transplant recipient
J Nożyński, M Zakliczyński, D Konecka-Mrówka, E Zembala-Nożyńska, D Lange, K Dąbrówka, T Męcik-Kronenberg, S Żegleń, R Przybylski, M ZembalaAnn Transplant 2009; 14(1): 64-65 :: ID: 880435
Abstract
Background: Interstitial fibrosis and variations in cardiocyte hypertrophy belong to the remodelling activities taking place in diseased myocardium especially in dilatative cardiomyopathy (DCM) and ischemic heart disease (IHD). The integrative morphometric measurements should reflect the main differences in histoarchitecture giving a valuable diagnostic tool. We sought to evaluate the quantitative morphology of the explanted diseased heart with DCM and IHD.
Material/Methods: The study groups encompassed 7 hearts with DCM and 8
hearts with IHD explanted during transplantation. The comparative group consisted of myocardial hypertrophy, while the control group were donor fragments. Method. Myocardial histoarchitecture was evaluated morphometrically in histological slides. The cardiocyte hypertrophy was estimated as nucleo-sarcoplasmic ratio calculated from nuclear and cardiocytic integrative measurements; cardiocyte diameter was additionally measured as mean chord, and myocardial interstitial fibrosis - as fibrosis surface area fraction in trichrome stained slides. The results were compared statistically and analyzed with discriminate analysis.
Results: The cardiocyte diameter showed no statistical significance between
myocardial hypertrophy and IHD and IHD and DCM, whereas nucleo-sarcoplasmic ratio showed differences in all comparisons with control groups. Myocardial fibrosis showed no differences between hypertrophy and control. Discriminate analysis pointed out the value of interstitial fibrosis and cardiocytes diameter in differentiating of analyzed groups, then proximity between control and hypertrophy and IHD and DCM and hypertrophy.
Conclusions: Myocardial fibrosis and cardiocytes' diameter may play a role as key parameters for diagnosis and differentiation of cardiomyopathies.
Keywords: Heart Transplantation
In Press
Original article
Effect of Medical Accessibility on Long-Term Survival in Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.944839
Original article
Lung Transplant Success in COVID-19 Patients Requiring V-V ECMO: One-Year Follow-UpAnn Transplant In Press; DOI: 10.12659/AOT.946088
Most Viewed Current Articles
05 Apr 2022 : Original article 13,221
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,677
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,822
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,535
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860